13:29:29 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande



2024-02-02 Bokslutskommuniké 2023
2023-10-27 Kvartalsrapport 2023-Q3
2023-07-20 Kvartalsrapport 2023-Q2
2023-05-08 Ordinarie utdelning CRAD B 0.00 SEK
2023-05-05 Kvartalsrapport 2023-Q1
2023-05-05 Årsstämma 2023
2023-01-26 Bokslutskommuniké 2022
2022-10-28 Kvartalsrapport 2022-Q3
2022-07-21 Kvartalsrapport 2022-Q2
2022-05-09 Ordinarie utdelning CRAD B 0.00 SEK
2022-05-06 Kvartalsrapport 2022-Q1
2022-05-06 Årsstämma 2022
2022-01-27 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-29 Kvartalsrapport 2021-Q2
2021-05-10 Ordinarie utdelning CRAD B 0.00 SEK
2021-05-07 Kvartalsrapport 2021-Q1
2021-05-07 Årsstämma 2021
2021-01-28 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-31 Kvartalsrapport 2020-Q2
2020-05-11 Ordinarie utdelning CRAD B 0.00 SEK
2020-05-08 Årsstämma 2020
2020-05-06 Kvartalsrapport 2020-Q1
2020-01-31 Bokslutskommuniké 2019
2019-12-17 Extra Bolagsstämma 2019
2019-10-25 Kvartalsrapport 2019-Q3
2019-08-30 Kvartalsrapport 2019-Q2
2019-05-09 Ordinarie utdelning CRAD B 0.00 SEK
2019-05-08 Årsstämma 2019
2019-05-08 Kvartalsrapport 2019-Q1
2019-02-08 Bokslutskommuniké 2018
2018-10-26 Kvartalsrapport 2018-Q3
2018-08-17 Kvartalsrapport 2018-Q2
2018-05-31 Årsstämma 2018
2018-05-18 Ordinarie utdelning CRAD B 0.00 SEK
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-31 Bokslutskommuniké 2017
2017-10-27 Kvartalsrapport 2017-Q3
2017-08-16 Kvartalsrapport 2017-Q2
2017-05-02 Ordinarie utdelning CRAD B 0.00 SEK
2017-04-28 Årsstämma 2017
2017-04-28 Kvartalsrapport 2017-Q1
2017-02-13 Bokslutskommuniké 2016
2016-11-17 Extra Bolagsstämma 2016
2016-11-14 Kvartalsrapport 2016-Q3
2016-08-24 Kvartalsrapport 2016-Q2
2016-05-09 Kvartalsrapport 2016-Q1
2016-04-15 Ordinarie utdelning CRAD B 0.00 SEK
2016-04-14 Årsstämma 2016
2016-02-08 Bokslutskommuniké 2015
2015-11-06 Kvartalsrapport 2015-Q3
2015-08-14 Kvartalsrapport 2015-Q2
2015-05-08 Kvartalsrapport 2015-Q1
2015-04-17 Ordinarie utdelning CRAD B 0.00 SEK
2015-04-16 Årsstämma 2015
2015-01-30 Bokslutskommuniké 2014
2014-11-07 Analytiker möte 2014
2014-11-07 Kvartalsrapport 2014-Q3
2014-08-15 Kvartalsrapport 2014-Q2
2014-05-16 Kvartalsrapport 2014-Q1
2014-04-17 Ordinarie utdelning CRAD B 0.00 SEK
2014-04-16 Årsstämma 2014
2014-02-17 Bokslutskommuniké 2013
2013-11-28 Kvartalsrapport 2013-Q3
2013-11-01 Analytiker möte 2013
2013-10-30 Extra Bolagsstämma 2013
2013-09-02 15-7 2013
2013-08-30 Kvartalsrapport 2013-Q2
2013-06-03 Ordinarie utdelning CRAD B 0.00 SEK
2013-05-31 Årsstämma 2013
2013-05-29 Kvartalsrapport 2013-Q1
2013-02-26 Bokslutskommuniké 2012
2012-12-04 Extra Bolagsstämma 2012
2012-11-28 Kvartalsrapport 2012-Q3
2012-09-04 Kvartalsrapport 2012-Q2
2012-06-04 Ordinarie utdelning CRAD B 0.00 SEK
2012-06-01 Årsstämma 2012
2012-05-24 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-11-25 Kvartalsrapport 2011-Q3
2011-08-26 Kvartalsrapport 2011-Q2
2011-05-26 Ordinarie utdelning CRAD B 0.00 SEK
2011-05-25 Årsstämma 2011
2011-05-24 Kvartalsrapport 2011-Q1
2011-02-11 Bokslutskommuniké 2010
2010-06-02 Ordinarie utdelning CRAD B 0.00 SEK
2010-06-01 Årsstämma 2010
2010-05-28 Kvartalsrapport 2010-Q1
2009-11-27 Kvartalsrapport 2009-Q3


ListaSmall Cap Stockholm
C-Rad är verksamma inom medicinteknik. Bolaget bedriver utveckling, tillverkning och försäljning av produkter och lösningar inom avancerad strålterapi. Verksamheten riktar sig huvudsakligen mot kliniker som erbjuder strålbehandling, där bolaget utöver kärnverksamheten erbjuder tillhörande installationstjänster och support. Kunderna återfinns på global nivå och huvudkontoret ligger i Uppsala.
2022-06-08 09:00:00

A second report detailing guidelines for clinicians on the use of SGRT (Surface Guided Radiation Therapy) has been issued. This time by ESTRO-ACROP SGRT group. The report includes European guidelines for procurement, acceptance, commissioning and QA of SGRT systems.

ESTRO-ACROP (The European Society for Radiotherapy and Oncology - The Advisory Committee for Radiation Oncology Practice) formed a dedicated workgroup focused on defining clinical workflows for the implementation of SGRT. The workgroup comprises representatives from the user community, academia and industry. The recently issued European guidelines aim to guide current and/or prospective SGRT users through the clinical workflow. Earlier this year, the AAPM (American Association of Physicist in Medicine) issued a report with guidelines for the clinical implementation and use of surface imaging.

The ESTRO report sets a strong focus on the SGRT workflow, covering the chain from imaging to treatment delivery. The authors are researchers from various clinical institutes with experience using SGRT. The report also includes a collection of criteria for decision-making for procurement of an SGRT system.

“This document presents the first European comprehensive guidelines on the commissioning, QA, and clinical use of SGRT systems… The technology of SGRT is evolving rapidly and the current guidelines may need to be adapted to future SGRT solutions.” [1] The report says. Hence underlining the incremental growth of SGRT usage worldwide and the need for guidelines on both usage but also procurement, much same as the AAPM report stated earlier this year: “The clinical use of surface imaging has increased dramatically with demonstrated utility for initial patient positioning, real-time motion monitoring, and beam gating in a variety of anatomical sites.” [2]

The European Society for Radiotherapy and Oncology (ESTRO) SGRT working group was initiated at the 3rd ESTRO physics workshop 2019 in Budapest. To establish a framework for the group, a study was carried out in 2020 which thus confirmed the need for common guidelines on the commissioning, QA, and clinical use of SGRT systems.

“This is a fantastic result of the inspiring ESTRO physics workshop in Budapest where the SGRT working group was created. Written by some of our most dedicated and experienced users, these first European guidelines are a valuable resource for both current and new practitioners to implement SGRT in their clinic”, says Mattias Nilsing, PhD, Product Manager C-RAD

ESTRO is a scientific and professional organization with 7,600 members, dedicated to formulation of new objectives, activities and structures for science dissemination, education and policy in radiation oncology. ACROP committee was formed in December 2012. Its aim is to advise the ESTRO Board and respective ESTRO councils in key areas such as guidelines, legislation and strategic development.

“It is C-RAD’s mission to ensure safety and efficiency in advanced radiation oncology. This comprehensive report is another milestone to standardize the safe and efficient implementation and operation of surface tracking technology for radiation therapy centers in Europe and worldwide” says Tim Thurn, CEO and President of C-RAD AB.

Read the complete report here: https://www.sciencedirect.com/science/article/pii/S0167814022041329

About C-RAD

C-RAD develops surface-guided imaging solutions for radiation therapy to allow highly accurate dose delivery to the tumor, and at the same time, to protect healthy tissue from unwanted exposure. Using high-speed 3D cameras combined with augmented reality, C-RAD supports the initial patient setup process and monitors the patient’s motion during treatment to ensure high confidence, an efficient workflow, and improved accuracy. C-RAD monitors the patient's motion without the use of tattoos or additional imaging dose, to deliver the highest level of patient safety and comfort.

C-RAD. Inspiring excellence in cancer treatment.

C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit http://www.c-rad.com

For further information:
Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email investors@c-rad.com

[1] 1 P.Freislederera, V.Batista, M. Öllers, et al. ESTRO-ACROP guideline on surface guided radiation therapy. Science Direct, 2022. https://www.sciencedirect.com/science/article/pii/S0167814022041329
[2] Al-Hallaq, HA, Cerviño, L, Gutierrez, AN, et al. AAPM task group report 302: Surface guided radiotherapy. Med. Phys.. 2022; 00: 00- 00. https://doi.org/10.1002/mp.15532